about
Discovery of Anticancer Agents of Diverse Natural OriginTrabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma ModelsTrial Watch: Immunotherapy plus radiation therapy for oncological indications.Prediction of clinical outcome and survival in soft-tissue sarcoma using a ten-lncRNA signature.Antitumor effects of pristimerin on human osteosarcoma cells in vitro and in vivo.Systemic Therapy in Metastatic or Unresectable Well-Differentiated/Dedifferentiated Liposarcoma.Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers.
P2860
Q28068341-BABE21AA-C6F6-462C-BD3A-A5779061450BQ33649056-8DED5890-0A8D-466B-9C33-02A4FD896078Q37308207-AB0A6CE7-2ECA-4429-83DA-39E48B2DB577Q43166037-943AFA42-75EC-4A95-A60A-A4C573821716Q47096522-6B5D37CC-4960-4150-B817-C61ED6319FC1Q47144710-16067A7E-2BFA-434A-ADCA-7E9B5CB42831Q55365628-9599B495-CC9B-490F-8A7D-AED9FEFAB137
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Trabectedin for the treatment of soft tissue sarcomas.
@en
type
label
Trabectedin for the treatment of soft tissue sarcomas.
@en
prefLabel
Trabectedin for the treatment of soft tissue sarcomas.
@en
P2860
P1476
Trabectedin for the treatment of soft tissue sarcomas
@en
P2093
Armando Santoro
P2860
P304
P356
10.1080/14656566.2016.1204295
P407
P577
2016-07-04T00:00:00Z